| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |